AI firm Aiforia and Mayo Clinic have exclusively licensed an AI model to improve prediction of colorectal cancer recurrence. The model analyses digitised tissue samples and combines this with clinical parameters to provide a personalised risk score. It will aid informed treatment decisions, potentially reducing unnecessary chemotherapy and better targeting high-risk patients to improve long-term outcomes. The Aiforia-Mayo Clinic collaboration also underlines a commitment to personalized medicine and continuous innovation.
Iranian Cyber Actors May Target “Entities of Interest” in US, Warns CISA
Summarize this content to a maximum of 60 words: CISA warns that Iranian cyber actors may target critical infrastructure in the United States.
